Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Depreciation and Depletion: 2019-2025

Historic Depreciation and Depletion for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to $8,000.

  • Eton Pharmaceuticals' Depreciation and Depletion fell 33.33% to $8,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $62,000, marking a year-over-year increase of 24.00%. This contributed to the annual value of $50,000 for FY2024, which is 13.64% up from last year.
  • According to the latest figures from Q3 2025, Eton Pharmaceuticals' Depreciation and Depletion is $8,000, which was up 100.00% from $4,000 recorded in Q2 2025.
  • Eton Pharmaceuticals' Depreciation and Depletion's 5-year high stood at $84,000 during Q1 2021, with a 5-year trough of $4,000 in Q2 2025.
  • Moreover, its 3-year median value for Depreciation and Depletion was $12,000 (2025), whereas its average is $13,091.
  • In the last 5 years, Eton Pharmaceuticals' Depreciation and Depletion tumbled by 75.00% in 2022 and then soared by 216.67% in 2024.
  • Eton Pharmaceuticals' Depreciation and Depletion (Quarterly) stood at $23,000 in 2021, then crashed by 43.48% to $13,000 in 2022, then declined by 7.69% to $12,000 in 2023, then spiked by 216.67% to $38,000 in 2024, then plummeted by 33.33% to $8,000 in 2025.
  • Its last three reported values are $8,000 in Q3 2025, $4,000 for Q2 2025, and $12,000 during Q1 2025.